recent publications

• academic article

  • Rice, G. P. A., Woelfel, E. L., Talbot, P. J., Braheny, S. L., Sipe, J. C., Knobler, R. L., Merigan, T. C., Oldstone, M. B. A. Immunological complications in multiple-sclerosis patients receiving interferon Annals of Neurology  1985 18:439-442  DOI:10.1002/ana.410180405  PMID:2416266
  • Sipe, J. C., Knobler, R. L., Braheny, S. L., Rice, G. P. A., Panitch, H. S., Oldstone, M. B. A. A neurologic rating-scale (nrs) for use in multiple-sclerosis Neurology  1984 34:1368-1372  PMID:6541311
  • Knobler, R. L., Panitch, H. S., Braheny, S. L., Sipe, J. C., Rice, G. P. A., Huddlestone, J. R., Francis, G. S., Hooper, C. J., Kaminlewis, R. M., Johnson, K. P., Oldstone, M. B. A., Merigan, T. C. Clinical-trial of natural alpha interferon in multiple-sclerosis Annals of the New York Academy of Sciences  1984 436:382-388  DOI:10.1111/j.1749-6632.1984.tb14809.x  PMID:6398020
  • Rice, G. P. A., Finney, D., Braheny, S. L., Knobler, R. L., Sipe, J. C., Oldstone, M. B. A. Disease-activity markers in multiple-sclerosis - another look at suppressor cells defined by monoclonal antibody-okt4, antibody-okt5, and antibody okt8 Journal of Neuroimmunology  1984 6:75-84  DOI:10.1016/0165-5728(84)90028-6  PMID:6233298
  • Knobler, R. L., Panitch, H. S., Braheny, S. L., Sipe, J. C., Rice, G. P. A., Huddlestone, J. R., Francis, G. S., Hooper, C. J., Kaminlewis, R. M., Johnson, K. P., Oldstone, M. B. A., Merigan, T. C. Systemic alpha-interferon therapy of multiple-sclerosis Neurology  1984 34:1273-1279  PMID:6384817
  • Rice, G. P. A., Sipe, J. C., Braheny, S. L., Knobler, R. L., Finney, D. A., Oldstone, M. B. A. The failure of monoclonal antibody-defined lymphocyte subsets to monitor disease-activity in patients with multiple-sclerosis Annals of the New York Academy of Sciences  1984 436:271-280  DOI:10.1111/j.1749-6632.1984.tb14799.x  PMID:6241819